FDA Warns of Unapproved Hair-Loss Product Linked to Side Effects
By I. Edwards HealthDay Reporter
THURSDAY, April 24, 2025 — A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left them battling sexual side effects, depression and even thoughts of suicide.
Now, the U.S. Food and Drug Administration (FDA) is warning the public about the risks.
The FDA warning is about a topical spray version of finasteride, a drug often sold online by telehealth companies like Hims, Keeps and Ro, The Wall Street Journal reported.
While the pill form of finasteride, known by the brand name Propecia, is FDA-approved to treat hair loss, the spray version is not.
"FDA has become aware of reports of adverse events involving compounded topical finasteride products potentially putting consumers at risk," the April 22 statement said.
"Currently, there is no FDA-approved topical formulation of finasteride," it continued. "Compounded topical finasteride products do not have FDA-approved labeling. There are potential serious risks associated with the use of compounded topical finasteride products."
The FDA warning follows a recent Wall Street Journal report describing men who said they experienced side effects after using finasteride prescriptions purchased from the telehealth companies Hims and Keeps.
Reported side effects include "erectile dysfunction, anxiety, suicidal ideation, brain fog, depression, fatigue, insomnia, decreased libido and testicular pain," the FDA said.
The FDA also warned that the spray could pose a risk to others, especially women. Finasteride can cause birth defects in male babies, so women are advised not to come in contact with the drug, the warning added.
Some users told the FDA that their doctors had said the spray version would not cause side effects.
Online health companies are allowed to sell these sprays through compounding pharmacies, which create drugs when patients need an alternative to FDA-approved medications.
While it's all legal, these companies are not held to the same advertising standards as traditional drugmakers, The Wall Street Journal reports.
In previous statements, both Hims and Keeps said they inform customers about potential risks on their websites and packaging.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-25 06:00
Read more

- Wildfire Smoke Increases Risk Of Mental Health Problems
- Medical Mistrust Could Be Harming Hep A Vaccination Rates Among Gay, Bisexual Men
- Fasting Outperforms Calorie Cutting, Clinical Trial Says
- Drug Overdose Deaths Rising Faster in Black Americans, Study Finds
- New Surgical Technique Preserves Erectile Function In Prostate Cancer Patients
- Novo Nordisk Warns Consumers About Counterfeit Ozempic (semaglutide) Injection 1 mg in the US
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions